Mats Holmberg

Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial

Benedikte Hasselbalch, Ulrik Lassen, Steinbjørn Hansen et al. · Neuro-Oncology · 2010 · 227 citations · Full text

Medicine, Oncology, Pharmacology +17

Immune system adaptation during gender-affirming testosterone treatment

Tadepally Lakshmikanth, Camila Rosat Consiglio, Fabian Sardh et al. · Nature · 2024 · 126 citations · Full text

Life Sciences, Endocrinology, Immunology +14

Muscle Strength, Size, and Composition Following 12 Months of Gender-affirming Treatment in Transgender Individuals

Anna Wiik, Tommy R. Lundberg, Eric Rullman et al. · The Journal of Clinical Endocrinology & Metabolism · 2019 · 111 citations

Social Sciences, Endocrinology, Gender +12

The Long-Term Outcome of Treatment for Graves' Hyperthyroidism

Gabriel Sjölin, Mats Holmberg, Ove Törring et al. · Thyroid · 2019 · 101 citations

Medicine, Endocrinology, Surgery +15

Impaired Quality of Life After Radioiodine Therapy Compared to Antithyroid Drugs or Surgical Treatment for Graves' Hyperthyroidism: A Long-Term Follow-Up with the Thyroid-Related Patient-Reported Outcome Questionnaire and 36-Item Short Form Health Status Survey

Ove Törring, Torquil Watt, Gabriel Sjölin et al. · Thyroid · 2019 · 94 citations

Medicine, Endocrinology, Surgery +17